Innovating Works

ARATANA THERAPEUTICS NV

Desconocido
FACTs: Fast Acting Virus Control Strategies for Production Animal Diseases ARATANA THERAPEUTICS NV tramitó un H2020: H2020-SMEInst-2014-2015 The objective of the FACTs project is to sign a term sheet with investors for ViroVet, an emerging Belgian biotech company, aimed at develop...
2015-04-08 - 2015-10-31 | Financiado
ANTIVIRALS: European Training Network on Antiviral Drug Development ARATANA THERAPEUTICS NV participó en un H2020: H2020-MSCA-ITN-2014 Viral infections are a major cause of disease, mortality and economic losses worldwide. Antiviral therapy is an essential instrument to cont...
2014-12-10 - 2019-09-30 | Financiado
EUVIRNA: European Training Network on RNA Virus Replication and Antiviral Drug Development ARATANA THERAPEUTICS NV participó en un FP7: Virus infections remain a major cause of disease, with dramatic costs in mortality, morbidity, and economic loss worldwide. There is an unme...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.